Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

CYCN Cyclerion Therapeutics

Watchlist
0.698
+0.015+2.20%
Close  02/06 16:00 ET
High
0.800
Open
0.700
Turnover
40.52K
Low
0.664
Pre Close
0.683
Volume
57.66K
Market Cap
30.36M
P/E(TTM)
Loss
52wk High
1.400
Shares
43.49M
P/E(Static)
Loss
52wk Low
0.350
Float Cap
19.12M
Bid/Ask %
66.67%
Historical High
21.000
Shs Float
27.39M
Volume Ratio
0.38
Historical Low
0.350
Dividend TTM
--
Div Yield TTM
--
P/B
1.84
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.21%
Amplitude
19.94%
Avg Price
0.702
Lot Size
1
Float Cap
19.12M
Bid/Ask %
66.67%
Historical High
21.000
Shs Float
27.39M
Volume Ratio
0.38
Historical Low
0.350
Dividend TTM
--
P/B
1.84
Dividend LFY
--
Turnover Ratio
0.21%
Amplitude
19.94%
Avg Price
0.702
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for serious and orphan diseases, through the use of soluble guanylate cyclase (sGC) pharmacology. Its product pipeline includes several sGC stimulators, a small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate (cGMP). The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.
CEO: Mr. Peter M. Hecht, PhD
Market: NASDAQ
Listing Date: 03/18/2019
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist